A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.
Saved in:
| Title: | A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge. |
|---|---|
| Authors: | Kitson, Geoff1 (AUTHOR), Byford, Marion1 (AUTHOR), Cass, Lindsey1 (AUTHOR), Howat, David1 (AUTHOR), Köhn, Brigitte1 (AUTHOR), Bisquera, Alessandra2 (AUTHOR), Catchpole, Andrew3 (AUTHOR), Noulin, Nicolas3 (AUTHOR), Thomson, Douglas1 (AUTHOR) douglas.thomson@pneumagen.com |
| Source: | Infectious Diseases & Therapy. Aug2025, Vol. 14 Issue 8, p1697-1714. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938229 |
|---|---|
| DOI: | 10.1007/s40121-025-01179-2 |
